AAAAAA

   
Results: 1-14 |
Results: 14
Primate skin allotransplantation with anti-CD154 monotherapy
Authors: Elster, EA Xu, H Tadaki, DK Burkly, LC Berning, JD Baumgartner, RE Cruzata, F Patterson, NB Harlan, DM Kirk, AD
Citation: Ea. Elster et al., Primate skin allotransplantation with anti-CD154 monotherapy, TRANSPLAN P, 33(1-2), 2001, pp. 675-676
Treatment with the humanized CD154-specific monoclonal antibody, hu5C8, prevents acute rejection of primary skin allografts in nonhuman primates
Authors: Elster, EA Xu, H Tadaki, DK Montgomery, S Burkly, LC Berning, JD Baumgartner, RE Cruzata, F Marx, R Harlan, DM Kirk, AD
Citation: Ea. Elster et al., Treatment with the humanized CD154-specific monoclonal antibody, hu5C8, prevents acute rejection of primary skin allografts in nonhuman primates, TRANSPLANT, 72(9), 2001, pp. 1473-1478
Successful conversion from conventional immunosuppression to anti-CD154 monoclonal antibody costimulatory molecule blockade in rhesus renal allograftrecipients
Authors: Cho, CS Burkly, LC Fechner, JH Kirk, AD Oberley, TD Dong, YC Brunner, KG Peters, D Tenhoor, CN Nadeau, K Yagci, G Ishido, N Schultz, JM Tsuchida, M Hamawy, MM Knechtle, SJ
Citation: Cs. Cho et al., Successful conversion from conventional immunosuppression to anti-CD154 monoclonal antibody costimulatory molecule blockade in rhesus renal allograftrecipients, TRANSPLANT, 72(4), 2001, pp. 587-597
Apoptosis and altered dendritic cell homeostasis in lupus nephritis are limited by anti-CD154 treatment
Authors: Kalled, SL Cutler, AH Burkly, LC
Citation: Sl. Kalled et al., Apoptosis and altered dendritic cell homeostasis in lupus nephritis are limited by anti-CD154 treatment, J IMMUNOL, 167(3), 2001, pp. 1740-1747
Prolonged islet graft survival in NOD mice by blockade of the CD40-CD154 pathway of T-cell costimulation
Authors: Molano, RD Berney, T Li, H Cattan, P Pileggi, A Vizzardelli, C Kenyon, NS Ricordi, C Burkly, LC Inverardi, L
Citation: Rd. Molano et al., Prolonged islet graft survival in NOD mice by blockade of the CD40-CD154 pathway of T-cell costimulation, DIABETES, 50(2), 2001, pp. 270-276
Costimulatory molecules are active in the human xenoreactive T-cell response but not in natural killer-mediated cytotoxicity
Authors: Tadaki, DK Craighead, N Saini, A Celniker, A Burkly, LC Lee, KP Chute, JP Harlan, DM Kirk, AD
Citation: Dk. Tadaki et al., Costimulatory molecules are active in the human xenoreactive T-cell response but not in natural killer-mediated cytotoxicity, TRANSPLANT, 70(1), 2000, pp. 162-167
Both early and delayed anti-CD40L antibody treatment induces a stable plaque phenotype
Authors: Lutgens, E Cleutjens, KBJM Heeneman, S Koteliansky, VE Burkly, LC Daemen, MJAP
Citation: E. Lutgens et al., Both early and delayed anti-CD40L antibody treatment induces a stable plaque phenotype, P NAS US, 97(13), 2000, pp. 7464-7469
Conditional disruption of hedgehog signaling pathway defines its critical role in hair development and regeneration
Authors: Wang, LC Liu, ZY Gambardella, L Delacour, A Shapiro, R Yang, JL Sizing, I Rayhorn, P Garber, EA Benjamin, CD Williams, KP Taylor, FR Barrandon, Y Ling, L Burkly, LC
Citation: Lc. Wang et al., Conditional disruption of hedgehog signaling pathway defines its critical role in hair development and regeneration, J INVES DER, 114(5), 2000, pp. 901-908
Role of CD154 in the secondary immune response: the reduction of pre-existing splenic germinal centers and anti-factor VIII inhibitor titer
Authors: Qian, JH Burkly, LC Smith, EP Ferrant, JL Hoyer, LW Scott, DW Haudenschild, CC
Citation: Jh. Qian et al., Role of CD154 in the secondary immune response: the reduction of pre-existing splenic germinal centers and anti-factor VIII inhibitor titer, EUR J IMMUN, 30(9), 2000, pp. 2548-2554
Treatment with humanized monoclonal antibody against CD154 prevents acute renal allograft rejection in nonhuman primates
Authors: Kirk, AD Burkly, LC Batty, DS Baumgartner, RE Berning, JD Buchanan, K Fechner, JH Germond, RL Kampen, RL Patterson, NB Swanson, SJ Tadaki, DK TenHoor, CN White, L Knechtle, SJ Harlan, DM
Citation: Ad. Kirk et al., Treatment with humanized monoclonal antibody against CD154 prevents acute renal allograft rejection in nonhuman primates, NAT MED, 5(6), 1999, pp. 686-693
Prolonged anti-CD40 ligand therapy improves primate cardiac allograft survival
Authors: Chang, AC Blum, MG Blair, KSA Scott, MA Brock, JE Thomas, DW Burkly, LC Miller, GG Pierson, RN
Citation: Ac. Chang et al., Prolonged anti-CD40 ligand therapy improves primate cardiac allograft survival, TRANSPLAN P, 31(1-2), 1999, pp. 95-95
Prolongation of primate cardiac allograft survival by treatment with anti-CD40 ligand (CD154) antibody
Authors: Pierson, RN Chang, AC Blum, MG Blair, KSA Scott, MA Atkinson, JB Collins, BJ Zhang, JP Thomas, DW Burkly, LC Miller, GG
Citation: Rn. Pierson et al., Prolongation of primate cardiac allograft survival by treatment with anti-CD40 ligand (CD154) antibody, TRANSPLANT, 68(11), 1999, pp. 1800-1805
Long-term survival and function of intrahepatic islet allografts in rhesusmonkeys treated with humanized anti-CD154
Authors: Kenyon, NS Chatzipetrou, M Masetti, M Ranuncoli, A Oliveira, M Wagner, JL Kirk, AD Harlan, DM Burkly, LC Ricordi, C
Citation: Ns. Kenyon et al., Long-term survival and function of intrahepatic islet allografts in rhesusmonkeys treated with humanized anti-CD154, P NAS US, 96(14), 1999, pp. 8132-8137
Long-term survival and function of intrahepatic islet allografts in baboons treated with humanized anti-CD154
Authors: Kenyon, NS Fernandez, LA Lehmann, R Masetti, M Ranuncoli, A Chatzipetrou, M Iaria, G Han, DM Wagner, JL Ruiz, P Berho, M Inverardi, L Alejandro, R Mintz, DH Kirk, AD Harlan, DM Burkly, LC Ricordi, C
Citation: Ns. Kenyon et al., Long-term survival and function of intrahepatic islet allografts in baboons treated with humanized anti-CD154, DIABETES, 48(7), 1999, pp. 1473-1481
Risultati: 1-14 |